Bioage Labs Stock Performance
| BIOA Stock | 19.10 0.41 2.10% |
BioAge Labs holds a performance score of 21 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioAge Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding BioAge Labs is expected to be smaller as well. Use BioAge Labs total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on BioAge Labs.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioAge Labs are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BioAge Labs sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 25 M | |
| Total Cashflows From Investing Activities | -366 K | |
| Free Cash Flow | -51.9 M |
BioAge Labs Relative Risk vs. Return Landscape
If you would invest 757.00 in BioAge Labs on October 31, 2025 and sell it today you would earn a total of 1,153 from holding BioAge Labs or generate 152.31% return on investment over 90 days. BioAge Labs is currently generating 1.7198% in daily expected returns and assumes 6.4889% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than BioAge, and 66% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioAge Labs Target Price Odds to finish over Current Price
The tendency of BioAge Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 19.10 | 90 days | 19.10 | about 7.61 |
Based on a normal probability distribution, the odds of BioAge Labs to move above the current price in 90 days from now is about 7.61 (This BioAge Labs probability density function shows the probability of BioAge Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days BioAge Labs has a beta of 0.19 suggesting as returns on the market go up, BioAge Labs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BioAge Labs will be expected to be much smaller as well. Moreover BioAge Labs has an alpha of 1.7001, implying that it can generate a 1.7 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). BioAge Labs Price Density |
| Price |
Predictive Modules for BioAge Labs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioAge Labs. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioAge Labs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioAge Labs is not an exception. The market had few large corrections towards the BioAge Labs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioAge Labs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioAge Labs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.70 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 4.47 | |
Ir | Information ratio | 0.26 |
BioAge Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioAge Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioAge Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioAge Labs is way too risky over 90 days horizon | |
| BioAge Labs appears to be risky and price may revert if volatility continues | |
| BioAge Labs has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (71.11 M) with loss before overhead, payroll, taxes, and interest of (3.74 M). | |
| BioAge Labs currently holds about 4.63 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 60.0% of the company shares are held by institutions such as insurance companies |
BioAge Labs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioAge Stock often depends not only on the future outlook of the current and potential BioAge Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioAge Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.7 M | |
| Cash And Short Term Investments | 354.3 M |
BioAge Labs Fundamentals Growth
BioAge Stock prices reflect investors' perceptions of the future prospects and financial health of BioAge Labs, and BioAge Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioAge Stock performance.
| Return On Equity | -0.26 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (11.27) % | |||
| Current Valuation | 484.17 M | |||
| Shares Outstanding | 41.75 M | |||
| Price To Earning | (0.84) X | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 138.30 X | |||
| EBITDA | (68.58 M) | |||
| Cash And Equivalents | 4.63 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 8.7 M | |||
| Debt To Equity | 172.10 % | |||
| Book Value Per Share | 7.74 X | |||
| Cash Flow From Operations | (51.52 M) | |||
| Earnings Per Share | 13.61 X | |||
| Total Asset | 358.23 M | |||
| Retained Earnings | (252.81 M) | |||
| Current Asset | 10.84 M | |||
| Current Liabilities | 29.68 M | |||
About BioAge Labs Performance
By analyzing BioAge Labs' fundamental ratios, stakeholders can gain valuable insights into BioAge Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioAge Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioAge Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioAmber Inc., an industrial biotechnology company, produces and sells renewable chemicals worldwide. BioAmber Inc. was founded in 2008 is headquartered in Montreal, Canada. BioAmber operates under Chemicals classification in USA and traded on OTC Market. It employs 85 people.Things to note about BioAge Labs performance evaluation
Checking the ongoing alerts about BioAge Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioAge Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioAge Labs is way too risky over 90 days horizon | |
| BioAge Labs appears to be risky and price may revert if volatility continues | |
| BioAge Labs has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (71.11 M) with loss before overhead, payroll, taxes, and interest of (3.74 M). | |
| BioAge Labs currently holds about 4.63 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 60.0% of the company shares are held by institutions such as insurance companies |
- Analyzing BioAge Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioAge Labs' stock is overvalued or undervalued compared to its peers.
- Examining BioAge Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioAge Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioAge Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioAge Labs' stock. These opinions can provide insight into BioAge Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioAge Stock analysis
When running BioAge Labs' price analysis, check to measure BioAge Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs is operating at the current time. Most of BioAge Labs' value examination focuses on studying past and present price action to predict the probability of BioAge Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs' price. Additionally, you may evaluate how the addition of BioAge Labs to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |